Cargando…

High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis

Lung cancer is the leading cause of human cancer mortality due to the lack of early diagnosis technology. The low-dose computed tomography scan (LDCT) is one of the main techniques to screen cancers. However, LDCT still has a risk of radiation exposure and it is not suitable for the general public....

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Shi-ang, Wu, Qian, Chen, Zhenpu, Zhang, Wei, Zhou, Yongchun, Mao, Kaining, Li, Jia, Li, Yuanyuan, Chen, Jie, Huang, Youguang, Huang, Yunchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175557/ https://www.ncbi.nlm.nih.gov/pubmed/34083687 http://dx.doi.org/10.1038/s41598-021-91276-2

Ejemplares similares

Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review
por: Zhang, Fan, et al.
Publicado: (2017)

Identification of Novel Biomarkers for Early Diagnosis of Atherosclerosis Using High-Resolution Metabolomics
por: Sardar, Syed Wasim, et al.
Publicado: (2023)

Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China
por: Yang, Yanlong, et al.
Publicado: (2018)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma
por: Dong, Jia-Mei, et al.
Publicado: (2023)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Metabolomics in the Diagnosis and Prognosis of COVID-19
por: Hasan, Mohammad Rubayet, et al.
Publicado: (2021)

Identification of Metabolomic Biomarkers of Seed Vigor and Aging in Hybrid Rice
por: Chen, Bing-Xian, et al.
Publicado: (2022)

Metabolomics Profiling and Diagnosis Biomarkers Searching for Drug-Induced Liver Injury Implicated to Polygonum multiflorum: A Cross-Sectional Cohort Study
por: Huang, Ying, et al.
Publicado: (2020)

The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers
por: Yang, Yanlong, et al.
Publicado: (2017)

Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages
por: Li, Jingjie, et al.
Publicado: (2018)

Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19
por: Occelli, Céline, et al.
Publicado: (2022)

Molecular Pathological Diagnosis of Thyroid Tumors Using Spatially Resolved Metabolomics
por: Huang, Luojiao, et al.
Publicado: (2022)

Identification of Circ_001569 as a Potential Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
por: Shen, Xianbo, et al.
Publicado: (2021)

LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
por: Huang, Xuanmei, et al.
Publicado: (2021)

Identification of faecal extracellular vesicles as novel biomarkers for the non‐invasive diagnosis and prognosis of colorectal cancer
por: Zhang, Zhaowei, et al.
Publicado: (2023)

Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
por: Ran, Hailiang, et al.
Publicado: (2022)

Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Ma, Yuhui, et al.
Publicado: (2021)

Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease
por: Jiang, Huali, et al.
Publicado: (2021)

Correction to: Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages
por: Li, Jingjie, et al.
Publicado: (2019)

Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy
por: Xu, Jia, et al.
Publicado: (2022)

In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis
por: Li, Yanlin, et al.
Publicado: (2022)

Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
por: Yang, Ruozhu, et al.
Publicado: (2022)

The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?
por: Iruzubieta, Paula, et al.
Publicado: (2015)

Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study
por: Liao, Yanbiao, et al.
Publicado: (2020)

Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment
por: Rispoli, Marianna Gabriella, et al.
Publicado: (2021)

Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma
por: Wang, Yanyun, et al.
Publicado: (2020)

Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020)

Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer
por: Jia, Sinong, et al.
Publicado: (2021)

Biomarkers of Metabolomics in Inflammatory Bowel Disease and Damp-Heat Syndrome: A Preliminary Study
por: Wu, Xingxing, et al.
Publicado: (2022)

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma
por: Han, Baoai, et al.
Publicado: (2023)

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction
por: Shu, Chin-Chung, et al.
Publicado: (2013)

High-resolution metabolomics of occupational exposure to trichloroethylene
por: Walker, Douglas I, et al.
Publicado: (2016)

Metabolomics and its potential in diagnosis, prognosis and treatment of rheumatic diseases
por: Smoleńska, Żaneta, et al.
Publicado: (2015)

Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review
por: Tokarz, Janina, et al.
Publicado: (2020)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population
por: Chen, Xiaoying, et al.
Publicado: (2016)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis
por: Chen, Chen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n8v1ljg5nhhst1olkbam00bgq4